arBtrage CAPITALIZING MARKETS checking… Sign in

Moleculin Biotech, Inc.

MBRX Health Care Biotechnology: Pharmaceutical Preparations
$2.40
▼ -4.4% Today
as of Jun 7, 07:20 ET
Last 30 days -6.25% Apr 28 → Jun 05
$2.03 $2.24 $2.44 $2.64 $2.85 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$2.57
High
$2.60
Low
$2.37
Volume
$218,374
Avg Vol
$225,828
Mkt Cap
$15M
P/E (TTM)
Beta
52w High
$24.00
52w Low
$1.79
Div Yield
Shares Out
$5M

Overview

52-week range
$1.79
$24
3% of range
Avg surprise (last 2)
-22.0%
Avg reaction (last 2)
+0.9%
50% positive

Earnings trends

EPS — actual vs estimate Actual Estimate
$-2.48$-2.03$-1.58$-1.14$-0.69 Actual $-0.69Est $-0.71Actual $-2.48Est $-1.69 Mar/2025Mar/2026
Revenue vs Net Income Revenue Net income
$-25M$-21M$-16M$-11M$-6M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $-2.48 $-1.69 -46.8% -259.4% +2.8% earnings
Tue May 13, 2025Mar/2025 $-0.69 $-0.71 +2.8% -0.9% earnings

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$0$0$0$0$0$0
Cost of revenue
Gross profit
Operating income$-8M$-6M$-6M$-6M$-7M$-6M
Net income$-13M$-25M$-18M$-6M$-7M$-6M
EPS (diluted)

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$10M$9M$7M$8M$8M$4M$9M$11M
Inventory
Total current assets$11M$10M$8M$9M$9M$5M$12M$14M
Total assets$23M$22M$20M$22M$21M$17M$23M$26M
Long-term debt
Total liabilities$8M$7M$47M$25M$7M$6M$16M$8M
Total equity$15M$15M$-27M$-4M$14M$11M$17M$19M

Implied volatility — last 90 days

No IV snapshots yet for MBRX.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

Sector peers